J&J | JNJ - Ordinary Share Capital



J&J reported $3.12B in Ordinary Share Capital for its fiscal quarter ending in March of 2025.


Ordinary Share Capital Change Date
AbbVie USD 18M 0 Dec/2024
Abbott USD 25.12B 28M Mar/2025
Amgen USD 538M 33.04B Jun/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
Baxter International USD 683M 0 Dec/2024
Bayer EUR 982.42M 1.53B Jun/2025
Becton, Dickinson and Co. USD 370.59M 406K Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
Boston Scientific USD 17M 0 Mar/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
CONMED USD 30.95M 30.63M Jun/2025
Cooper Companies USD 198.8M 177M Jul/2025
Dexcom USD 392.2M 391.8M Jun/2025
Edwards Lifesciences USD 654.8M 500K Dec/2024
Eli Lilly USD 946.83M 354.23M Jun/2025
Gilead Sciences USD 1.24B 3M Jun/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
Globus Medical USD 135.05M 134.92M Jun/2025
Hologic USD 222.22M 219.22M Jun/2025
Insulet USD 70.39M 70.29M Jun/2025
Integra LifeSciences USD 77.92M 77M Jun/2025
Intuitive Surgical USD 358.42M 358.02M Jun/2025
J&J USD 3.12B 0 Mar/2025
Medtronic USD 128K 128K Apr/2025
Merck USD 1.79B 0 Mar/2025
Merit Medical Systems USD 59.22M 658.89M Jun/2025
Novartis USD 793M 0 Dec/2024
Pfizer USD 5.68B 5.2B Jun/2025
Regeneron Pharmaceuticals USD 106.4M 106.4M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sanofi 1.22B 36.5M Jun/2025
Stryker USD 382.3M 344.3M Jun/2025
Tandem Diabetes Care USD 67.53M 67.46M Jun/2025
Teva Pharmaceutical Industries USD 1.15B 1.09B Jun/2025
Vertex Pharmaceuticals USD 256.3M 253.7M Jun/2025
Zimmer Biomet Holdings USD 197.9M 194.7M Jun/2025
Zoetis USD 443.95M 438.95M Jun/2025